Literature DB >> 12204865

Health-related quality of life and mortality in male patients with chronic obstructive pulmonary disease.

Antònia Domingo-Salvany1, Rosa Lamarca, Montserrat Ferrer, Judith Garcia-Aymerich, Jordi Alonso, Miquel Félez, Ahmad Khalaf, Ramon M Marrades, Eduard Monsó, Joan Serra-Batlles, Josep M Antó.   

Abstract

To assess whether generic and specific health-related quality of life (HRQL) are independently associated with total and specific mortality in patients with chronic obstructive pulmonary disease (COPD), we followed until 1999 a cohort of 321 male patients with COPD, recruited in 1993-1994 at outpatient respiratory clinics. Baseline characteristics recorded under stable clinical conditions included forced spirometry, arterial blood gas tensions, dyspnea scales, 11 comorbid conditions, St. George's Respiratory Questionnaire (SGRQ), and SF-36 Health Survey. Vital status was assessed through reinterviews, the Mortality Register, and clinical records. Subjects who died (106) were older (69.8 versus 62.5 years) (p < 0.001), had lower body mass index (BMI) (25.4 versus 27.1) (p < 0.01), were more impaired in the clinical characteristics studied (%FEV(1), 34.0 versus 51.0) (p < 0.001), and had long-term oxygen therapy more frequently (31% versus 7%) (p < 0.001). Survival was shorter when worse HRQL was reported. SGRQ total and SF-36 physical summary scores were independently associated with total and respiratory mortality in Cox models, including age, FEV(1), and BMI. The total mortality-standardized hazard ratios for both HRQL measures were 1.3, whereas those for FEV(1) were 1.6. HRQL measures provide independent and relevant information on the health status of male patients with COPD. Their use should be considered for a more thorough evaluation and staging of patients with COPD.

Entities:  

Mesh:

Year:  2002        PMID: 12204865     DOI: 10.1164/rccm.2112043

Source DB:  PubMed          Journal:  Am J Respir Crit Care Med        ISSN: 1073-449X            Impact factor:   21.405


  95 in total

Review 1.  Assessment of progression of COPD: report of a workshop held in Leuven, 11-12 March 2004.

Authors:  M Decramer; R Gosselink; M Rutten-Van Mölken; J Buffels; O Van Schayck; P-A Gevenois; R Pellegrino; E Derom; W De Backer
Journal:  Thorax       Date:  2005-04       Impact factor: 9.139

2.  Health-related quality of life as a predictor of mortality among community-dwelling older persons.

Authors:  Su-Ying Tsai; Lin-Yang Chi; Chen-Hsen Lee; Pesus Chou
Journal:  Eur J Epidemiol       Date:  2007-01-11       Impact factor: 8.082

3.  Development of an economic model to assess the cost effectiveness of treatment interventions for chronic obstructive pulmonary disease.

Authors:  Michael Spencer; Andrew H Briggs; Ronald F Grossman; Laureen Rance
Journal:  Pharmacoeconomics       Date:  2005       Impact factor: 4.981

4.  Effect of a Motivational Interviewing-Based Health Coaching on Quality of Life in Subjects With COPD.

Authors:  Hamid Rehman; Craig Karpman; Kristin Vickers Douglas; Roberto P Benzo
Journal:  Respir Care       Date:  2017-06-13       Impact factor: 2.258

5.  Characterisation of phenotypes based on severity of emphysema in chronic obstructive pulmonary disease.

Authors:  Hironi Makita; Yasuyuki Nasuhara; Katsura Nagai; Yoko Ito; Masaru Hasegawa; Tomoko Betsuyaku; Yuya Onodera; Nobuyuki Hizawa; Masaharu Nishimura
Journal:  Thorax       Date:  2007-06-15       Impact factor: 9.139

6.  Evolution of the COPD Assessment Test score during chronic obstructive pulmonary disease exacerbations: determinants and prognostic value.

Authors:  Darwin Feliz-Rodriguez; Santiago Zudaire; Carlos Carpio; Elizabet Martínez; Antonia Gómez-Mendieta; Ana Santiago; Rodolfo Alvarez-Sala; Francisco García-Río
Journal:  Can Respir J       Date:  2013 Sep-Oct       Impact factor: 2.409

7.  BODE-Index vs HADO-score in chronic obstructive pulmonary disease: Which one to use in general practice?

Authors:  Cristóbal Esteban; José M Quintana; Javier Moraza; Myriam Aburto; Urko Aguirre; José I Aguirregomoscorta; Susana Aizpiri; Luis V Basualdo; Alberto Capelastegui
Journal:  BMC Med       Date:  2010-05-24       Impact factor: 8.775

Review 8.  Tiotropium HandiHaler in the treatment of COPD: a safety review.

Authors:  Steven Kesten; Bart Celli; Marc Decramer; Inge Leimer; Donald Tashkin
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2009-11-29

9.  Assessment of a primary and tertiary care integrated management model for chronic obstructive pulmonary disease.

Authors:  Ignasi Bolíbar; Vicente Plaza; Mariantònia Llauger; Ester Amado; Pedro A Antón; Ana Espinosa; Leandra Domínguez; Mar Fraga; Montserrat Freixas; Josep A de la Fuente; Iskra Liguerre; Casimira Medrano; Meritxell Peiro; Mariantònia Pou; Joaquin Sanchis; Ingrid Solanes; Carles Valero; Pepi Valverde
Journal:  BMC Public Health       Date:  2009-02-24       Impact factor: 3.295

10.  Tiotropium and exercise training in COPD patients: effects on dyspnea and exercise tolerance.

Authors:  Nicolino Ambrosino; Katia Foglio; Gianni Balzano; Pier Luigi Paggiaro; Patrizia Lessi; Steven Kesten
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2008
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.